IPP Bureau
Biocon renames Irish step-down subsidiary as Biocon Biologics Ireland
By IPP Bureau - April 06, 2026
Move aligns global biologics identity under the Biocon Biologics brand
Enveda’s experimental oral therapy shows breakthrough results in atopic dermatitis trial
By IPP Bureau - April 06, 2026
Safety was equally impressive. ENV-294 was well tolerated
AIIMS New Delhi partners with MediSim VR to advance VR skill training in medical education
By IPP Bureau - April 06, 2026
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management
By IPP Bureau - April 06, 2026
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy
By IPP Bureau - April 06, 2026
He brings extensive cross-functional expertise built through leadership roles
Akumentis Healthcare appoints Sachhin Misshra as President
By IPP Bureau - April 06, 2026
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
Experts advocate holistic Semaglutide use as therapy goes off patent in India
By IPP Bureau - April 06, 2026
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Healthcare major QCIL signs solar power pacts with AMPIN and Radiance
By IPP Bureau - April 06, 2026
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
Sun Pharma appoints former PwC India COO Satyavati Berera as independent director
By IPP Bureau - April 05, 2026
Board approves five-year appointment, subject to shareholder nod through postal ballot
Max Healthcare allots 57,461 equity shares under ESOP 2022
By IPP Bureau - April 05, 2026
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
KIMS enters Kerala with 20-year operations pact for Avitis Super Speciality Hospital in Palakkad
By IPP Bureau - April 05, 2026
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
Dr Jitendra Singh calls for India-led biosimilar insulin scale-up amid global supply concerns
By IPP Bureau - April 05, 2026
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported
By IPP Bureau - April 05, 2026
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
AstraZeneca combo therapy shows breakthrough in liver cancer trial
By IPP Bureau - April 05, 2026
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
SRM Prime Hospital's India-first heart procedure saves 73-year-old after standard options fail
By IPP Bureau - April 05, 2026
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
